News – Page 1120 – Endpoints News

Verily joins up with Duke, Stanford to enlist an army of consumers to put its next-gen sensor tech to the test — ...

9 years ago

Bristol-Myers preps second checkpoint/cancer vax combo study under its $1B Bavarian Nordic pact

9 years ago

Novartis ties up with the virtual biotech Parvus to try a new approach on Type 1 diabetes

9 years ago

Ex-Dendreon chief Mitch Gold steers his way back to the public markets, looking to jumpstart a new clinical program

9 years ago

Hey Pfizer, Novartis and Eli Lilly. G1 Therapeutics says it can beat all of you in its $115M IPO

9 years ago

Celgene, Ionis ink China drug development pacts; Motif touts positive PhIII antibiotic data

9 years ago

Incyte doubles down on CEO Hervé Hoppenot’s pay package — big but not stupid

9 years ago

A final flop signals the bitter end to Circassia’s big plans for allergy R&D

9 years ago

Novartis is keeping JULIET in hiding, but the FDA takes a peek and hands over a ‘breakthrough’ title

9 years ago

Novartis joins forces with Allergan, pushing a NASH combo into late-stage development

9 years ago

Ramaswamy’s Enzyvant scores a double-barreled FDA commitment to help hustle a rare disease drug through its BLA

9 years ago

CRISPR Therapeutics, Casebia ink AAV deal with StrideBio; Puma gets an AdComm date; Merrimack names new R&D chief

9 years ago

Report: Hanmi’s failure to report patient death in olmutinib study broke South Korea’s medical laws

9 years ago

OncoMed’s bad, no good, disastrous month continues as another PhII flops, PhIb trial is shuttered

9 years ago

The UK isn't giving up on keeping the European Medicines Agency's HQ in London without a fight

9 years ago

Roche says its new interim update on hemophilia A drug is positive. But it’s hard to gauge.

9 years ago

Scoop: Juno recruits Sunil Agarwal as R&D chief, opening a Bay Area facility in research revamp

9 years ago

In a stunning setback, FDA spurns Eli Lilly’s marketing application for baricitinib, demands more data

9 years ago

Chalk up one more biotech startup for MIT’s Bob Langer

9 years ago

New CEOs at Axovant, Destiny and Organovo mark a busy week for the biotech jobs scene

9 years ago

Apple’s ‘super secret’ plan to revolutionize diabetes care; Thiel’s Breakout Labs takes on 4 more startups

9 years ago

We don’t know when (exactly) Lilly will announce the FDA’s baricitinib decision, but watch out for the looming ...

9 years ago

Editas’ rivals appeal a recent setback on patent fight, mapping a global war for CRISPR supremacy

9 years ago

Roche, Biogen handing over $470M in cash to bag two drug programs from Bristol-Myers Squibb

9 years ago

First page Previous page 1117 1118 111911201121 1122 1123 Next page Last page